September/October 2014

Cyramza by Eli Lilly

October 22, 2014

New Drug Review

Cyramza (ramucirumab) was approved for treatment of patients with advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma after disease progression.

Specialty in Retail: What Does It Take to Participate?

October 21, 2014

Features

A retailer's decision to get involved in the specialty pharmacy marketplace should be an informed one that encompasses careful research and a full understanding of all of the stakeholder requirements.

"Good Enough" Is Not Good Enough

October 21, 2014

Features

The use of a virtual health assistant provides an ongoing measurement of patient outcomes and a precise picture of disease activity, allowing clinicians to better tailor medication therapy to a patient's needs.